PPA
ECYT

Parametric Portfolio Associates’s Endocyte, Inc. Common Stock ECYT Stock Holding History

Parametric Portfolio Associates’s Portfolio ECYT Stock Details ECYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-11,303
Closed -$201K – 4022
2018
Q3 		$201K Buy
+11,303
New +$194K ﹤0.01% 3763
2017
Q3 		– Sell
-90,620
Closed -$136K – 4081
2017
Q2 		$136K Sell
90,620
-71,709
-44% -$154K ﹤0.01% 3892
2017
Q1 		$417K Buy
162,329
+59,454
+58% +$138K ﹤0.01% 3283
2016
Q4 		$262K Buy
102,875
+73,667
+252% +$212K ﹤0.01% 3490
2016
Q3 		$90K Buy
29,208
+9,351
+47% +$29.1K ﹤0.01% 3693
2016
Q2 		$64K Buy
19,857
+4,592
+30% +$16.8K ﹤0.01% 3765
2016
Q1 		$47K Buy
+15,265
New +$49.8K ﹤0.01% 3929
2014
Q2 		– Sell
-10,864
Closed -$259K – 3836
2014
Q1 		$259K Sell
10,864
-3
-0% -$43 ﹤0.01% 3514
2013
Q4 		$116K Sell
10,867
-10,828
-50% -$120K ﹤0.01% 3709
2013
Q3 		$289K Buy
21,695
+8,853
+69% +$140K ﹤0.01% 3419
2013
Q2 		$169K Buy
+12,842
New +$173K ﹤0.01% 3508

Other funds holding ECYT

OTC
Opera Trading Capital Paris, France $419M AUM 0.58% 1-Year Est. Return
CA
Claro Advisors Boston, Massachusetts $830M AUM 21.8% 1-Year Est. Return

Parametric Portfolio Associates's ECYT Position: Q4 2018 in Review

Parametric Portfolio Associates sold out of Endocyte, Inc. Common Stock (ECYT) in Q4 2018, closing a stake of 11,303 shares — an estimated $201K sold.

Parametric Portfolio Associates first reported a position in ECYT in Q2 2013 and held it in 11 quarters. The position peaked at $417K in Q1 2017. 2 funds tracked by Wall St. Rank hold ECYT as of Q4 2018.

  • Parametric Portfolio Associates reported no remaining Endocyte, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
  • Parametric Portfolio Associates sold 11,303 Endocyte, Inc. Common Stock shares in Q4 2018, an estimated $201K.
  • Parametric Portfolio Associates first reported a position in Endocyte, Inc. Common Stock in Q2 2013 and held it in 11 quarters.
  • Parametric Portfolio Associates's Endocyte, Inc. Common Stock position peaked at $417K in Q1 2017.
  • 2 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q4 2018.

Based on Parametric Portfolio Associates's 13F filing for Q4 2018, filed 14 Feb 2019.